Latest Strategy News

GreenTech Metals has appointed James Rattenbury as CEO to spearhead development of its Munni Munni platinum group metals project, signalling a strategic push in the West Pilbara mining hub.

Swift TV Ltd has secured two four-year reseller contracts to deliver its children’s entertainment content at Sydney Children’s Hospital Randwick and Westmead, marking a strategic move into the hospital sector.

Macmahon Holdings has reported a robust first half of FY26, delivering double-digit growth in revenue and earnings alongside a significant dividend increase and reaffirmed full-year guidance.

TradeWindow has successfully closed its NZ$5.9 million Share Purchase Plan, with retail investors contributing around NZ$217,000. Shares will be allotted at NZ$0.25 each, matching the previous placement price.

Reliance Worldwide Corporation reported a 4.6% revenue decline and a 34.9% drop in net profit for H1 FY2026, citing US tariffs and weaker demand in key markets. The company balances challenges with cost savings and a shareholder-friendly capital return strategy.

Challenger Limited reported a solid first half of FY26 with a 2% rise in normalised net profit after tax and record annuity sales. The company also announced a $150 million on-market share buy-back, reflecting confidence in its strong capital position.

Osteopore Limited has drawn down the second tranche of its redeemable convertible notes, raising A$500,000 as part of a broader A$20 million funding agreement with Advance Opportunities Fund. The funds are earmarked to support ongoing operations and future growth initiatives.

Qualitas Limited reports robust interim results for the six months to December 2025, driven by strong deployment and expanding investor mandates, reaffirming its FY26 guidance.

Qualitas Limited reported a robust interim result for the six months to December 2025, with net profit rising 27% and funds under management expanding 18% to $10.9 billion. The company’s focus on real estate private credit and build-to-rent sectors underpinned strong capital deployment and fee growth.

PEXA Group has announced its strategic exit from majority-owned Digital Solutions businesses, triggering a $26 million impairment and a restatement of its FY26 financial guidance. The move signals a sharper focus on core operations amid restructuring costs.

Ophir High Conviction Fund reported a 6.24% increase in net assets to $765 million for the half-year ended December 2025, despite a sharp 62.7% fall in operating profit. The Fund’s portfolio performance slowed significantly, prompting no distributions during the period.

Vita Life Sciences has reported a strong FY2025 with record revenue of $93.3 million and net profit after tax rising 18.8%, while declaring a 14.0 cents per share dividend.